SOURCES SOUGHT
R -- Resource for the Collection and Evaluation of Human Tissue, Cells, and Bio-fluids from Donors with an Epidemiologic Profile
- Notice Date
- 1/7/2015
- Notice Type
- Sources Sought
- NAICS
- 622110
— General Medical and Surgical Hospitals
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- N02RC51010-82
- Archive Date
- 2/5/2015
- Point of Contact
- Paul Martha, , Charlotte M,
- E-Mail Address
-
paul.martha@nih.gov,
(paul.martha@nih.gov, ontract)
- Small Business Set-Aside
- N/A
- Description
- HHS-NIH-NCI-SBSS-ETSB-51010-82 NOTICE INFORMATION Agency/Office: National Institutes of Health Location: National Cancer Institute, Office of Acquisitions Title: Resource for the Collection and Evaluation of Human Tissue, Cells, and Bio-fluids from Donors with an Epidemiologic Profile This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. This requirement is assigned a code of 622110 in the North American Industry Classification System (NAICS), and the size standard for such requirements is $38.5 Million per annum. Statements should also include an indication of current certified business status; this indication should be clearly marked on the first page of your capability statement (preferably placed under the eligible small business concern's name and address) as well as the eligible business concern's name, point of contact, address, and DUNS number. The Laboratory of Human Carcinogenesis (LHC), Division of the Center for Cancer Research (CCR), National Cancer Institute (NCI) is seeking capability statements from all eligible Small Businesses as stated above. THERE IS NO SOLICITATION AVAILABLE. THIS IS STRICTLY FOR MARKET RESEARCH. Background: This contract is the essential resource serving the CCR, LHC research program. It supports molecular epidemiology studies of human lung, breast, prostate, liver and pancreatic cancer; as well as, the molecular pathogenesis and translational studies of all these diseases. LHC studies the induction of cancer directly in human tissues and cells. This requires a reliable source of fresh, professionally obtained human specimens. The contract initially began as a pilot to obtain tissues for the experimental development of conditions to culture human specimens as organ and cellular tissues. The focus at that time was to obtain case-series cancer and adjacent uninvolved tissues from consented patients as they underwent surgery. Cancer cases have been obtained primarily from the Baltimore Veteran's Administration Hospital, the University of Maryland Medical Center, and Johns Hopkins University Hospital (historically). Beginning in 1996, focus shifted to case-control studies which still included collection of material from cancer patients, but also healthy population based controls, recruited from the Maryland Department of Motor Vehicles records. Population controls were recruited based on matching to the cancer cases by geographic location (Baltimore City, Maryland and surrounding selected counties), gender, and race (Caucasian, African-American, and Asian). In addition to human tissues for research, the resource provides corresponding epidemiology profiles that include occupational histories, personal health history, family health history, smoking information, and exercise information via informed consent. Addition of medical record abstracts and pathological reports complete questionnaires. Personal Identifying Information is excluded when data or samples are delivered to the NIH. Further, the contract provides histology slides and histopathological interpretations by professionals. Unstained regular, standard and immuno-stained slides will be made available for staining and interpretation in LHC. Three (3) previous contracts awarded competitively and entitled "Resource for the Collection and Evaluation of Human Tissues and Cells from Donors with an Epidemiology Profile." These included contracts: 00261199705D261971006, awarded 05/01/1997; 00261200105D261017011, awarded 05/31/2001, HHSN261200577000C, awarded 05/01/2005; and the current contract HHSN261201000117C, awarded 09/30/2010. Purpose and Objective: The scope of this contract is to provide ongoing research to support molecular epidemiology studies of human lung, breast, liver and pancreas cancer and also provide human cancer and non-cancer tissue and primary cells for both in vitro and in vivo studies allowing the LHC to conduct studies. Project Requirements: Organization will be required to: 1) Identify and recruit cancer cases and population-based controls 2) Obtain informed consent and maintain Internal Review Board approvals 3) Collect and store subject interview data, and 4) Collect and process biological specimens and transfer the de-identified materials (data and specimens) to the LHC. Anticipated Period of Performance: It is anticipated that one (1) cost reimbursement contract will be awarded with one (1) year base plus four (4) one (1) year option periods beginning on or about September 28, 2015. Other Important Information: Mandatory Criteria: This criterion establishes conditions that must be met at the time of receipt of award. Companies that fail to meet these requirements will not be considered further for award. Capability Statements must clearly document your ability in the following area: •Must demonstrate the ability to facilitate delivery of non-frozen viable tissues to the NIH campus within two (2) hours of receiving them from the pathologist, at all times of the day. The offeror is required to provide their address and distance from the NIH campus located at 9000 Rockville Pike, Bethesda, MD 20892-1360. The offeror must be able to demonstrate past performance and expertise in (1) Technical Approach, (2) Organizational Experience, (3) Personnel and (4) Facilities.   Capability Statement/Information Sought: To be deemed capable of providing services that meet the LHC requirements, please submit a written capability statement demonstrating your ability and experience. Submission Information: Interested qualified small business organizations should submit a tailored capability statement for this requirement, not to exceed 15 single-sided pages (including all attachments, resumes, charts, etc) presented in single-space and using a 12-point font size minimum, that clearly details the ability to perform the aspects of the notice described above. Statements should also include an indication of current certified small business status; this indication should be clearly marked on the first page of your capability statement (preferably placed under the eligible small business concern's name and address), as well as the eligible small business concerns name, point of contact, address and DUNS number. Responses will be reviewed only by NIH personnel and will be held in a confidential manner. All capability statements sent in response to this sources sought notice must be submitted electronically (via email) to Paul Martha, Contract Specialist, at paul.martha@nih.gov in MS Word or Adobe Portable Document Format (PDF) by January 21, 2015 4:00 PM, EST. All responses must be received by the specified due date and time in order to be considered. CAPABILITY STATEMENTS RECEIVED AFTER THIS DATE AND TIME WILL NOT BE CONSIDERED. No collect calls or facsimile transmissions will be accepted. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/N02RC51010-82/listing.html)
- Record
- SN03610933-W 20150109/150107234813-89f5f7d93fb12a0954fd7d39add4e211 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |